Division of Cannabis Regulation Notice of Recall – Updated
April 10, 2025
Topic: Notice of Mandatory Marijuana Product Recall Update
Issue: The Division of Cannabis Regulation (DCR) is issuing an updated alert to patients and consumers about a mandatory product recall. Pursuant to 19 CSR 100-1.100(4)(P), DCR may issue a public notice of recall where marijuana product presents a potential threat to health and safety.
No adverse reactions for this product have been reported to DCR at this time.
On August 14, 2023, DCR issued a recall on manufactured products sold to dispensaries and manufacturers from infused product manufacturer, Delta Extraction, LLC, MAN000022.
On February 18, 2025, the Administrative Hearing Commission (AHC) issued an order finding grounds exist for the recall because Delta Extraction used unregulated cannabis in its distillate. The AHC also directed the Department to review the recall list and remove Delta’s Midwest Magic products as those were sourced from regulated cannabis. During that review, DCR has discovered additional marijuana product containing THC oil derived from the Delta Extraction unregulated cannabis. These additional products are included in the new recall documents.
Patients and consumers who have purchased the recalled product should discontinue use. All unused product(s) should be discarded or returned to the dispensary facility where purchased. Returned products will not count toward a patient’s purchase limit. For more information on returns, please contact the dispensary facility where the product was purchased. For information on recalled items, please go to Product Recalls.
Anyone who thinks that they may be experiencing adverse reactions should seek immediate medical attention. Patients and consumers are reminded that any adverse reactions should be reported by emailing CannabisComplaints@health.mo.gov or filling out a complaint form located here.
Licensees are encouraged to reach out to their compliance officer or CannabisCompliance@health.mo.gov if they have any questions.
Jennifer Zamkus, Director
Section for Compliance and Enforcement
Division of Cannabis Regulation
Department of Health and Senior Services